Loading...

Abbott Laboratories (NYSE:ABT)

109.08 USD -0.37 USD ( -0.34% )
Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist

EV/EBITDA
Enterprise Value to EBITDA

The Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
=
Enterprise Value
/
EBITDA
Current EV/EBITDA
ABT
15.5
Median EV/EBITDA
ABT
21
Industry EV/EBITDA
Health Care
10.6

EV/EBITDA History

Statistics
Enterprise Value to EBITDA

1 Year 3 Years 5 Years
Average 18.6 21.3 21.2
Median 19 21 21
Min 16 16 16
Max 21.2 27 27

History Chart
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
16.9
2-Years Forward
EV/EBITDA
16.8
3-Years Forward
EV/EBITDA
15

EV/EBITDA Across Competitors

ABT Competitors
Abbott Laboratories Competitors

Country Company Market Cap EV/EBITDA
US
Abbott Laboratories
NYSE:ABT
191B USD 15.5
IE
Medtronic PLC
NYSE:MDT
120B USD 13.5
US
Stryker Corp
NYSE:SYK
76.8B USD 20.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
74.7B USD 30.9
US
Becton Dickinson and Co
NYSE:BDX
71.3B USD 17.4
US
Edwards Lifesciences Corp
NYSE:EW
60.2B USD 31.1

Relative Valuation Report

View full relative valuation report for Abbott Laboratories, which takes into account all ABT`s valuation multiples.

See Also

Similar Stocks